Readability of online patient resources in gynecologic oncology: Too difficult for our patients to read? (Englisch)
- Neue Suche nach: Vargas, R.
- Neue Suche nach: Esselen, K.
- Neue Suche nach: Muto, M.
- Neue Suche nach: Vargas, R.
- Neue Suche nach: Esselen, K.
- Neue Suche nach: Muto, M.
In:
GYNECOLOGIC ONCOLOGY
;
136
, 2
;
411
;
2015
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Readability of online patient resources in gynecologic oncology: Too difficult for our patients to read?
-
Beteiligte:
-
Erschienen in:GYNECOLOGIC ONCOLOGY ; 136, 2 ; 411
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam
-
Erscheinungsdatum:01.01.2015
-
Format / Umfang:411 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.992
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.992 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 136, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 175
-
Transitioning to a new era in cervical cancer screeningSchiffman, M. / Wentzensen, N. et al. | 2015
- 178
-
Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidanceHuh, W. K. / Ault, K. A. / Chelmow, D. / Davey, D. D. / Goulart, R. A. / Garcia, F. A. / Kinney, W. K. / Massad, L. S. / Mayeaux, E. J. / Saslow, D. et al. | 2015
- 183
-
American College of Surgeons Clinical Congress 2014Argenta, P. / Edelson, M. I. et al. | 2015
- 185
-
International Gynecologic Cancer Society (IGCS) 2014: Meeting reportFotopoulou, C. / Coleman, R. L. et al. | 2015
- 189
-
Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening testWright, T. C. / Stoler, M. H. / Behrens, C. M. / Sharma, A. / Zhang, G. / Wright, T. L. et al. | 2015
- 198
-
Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasionMatsuo, K. / Yoshino, K. / Hasegawa, K. / Murakami, R. / Ikeda, Y. / Adachi, S. / Hiramatsu, K. / Yokoyama, T. / Nishimura, M. / Sheridan, T. B. et al. | 2015
- 205
-
The prognostic value of dividing epithelial ovarian cancer into type I and type II tumors based on pathologic characteristicsPrahm, K. P. / Karlsen, M. A. / Hogdall, E. / Scheller, N. M. / Lundvall, L. / Nedergaard, L. / Christensen, I. J. / Hogdall, C. et al. | 2015
- 212
-
Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10Hong, S. H. / Lee, S. / Kim, H. G. / Lee, H. J. / Jung, K. H. / Lee, S. C. / Lee, N. R. / Yun, J. / Woo, I. S. / Park, K. H. et al. | 2015
- 218
-
Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503)Matsumoto, K. / Katsumata, N. / Shibata, T. / Satoh, T. / Saitou, M. / Yunokawa, M. / Takano, T. / Nakamura, K. / Kamura, T. / Konishi, I. et al. | 2015
- 224
-
Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the ''cisplatin era''Solheim, O. / Trope, C. G. / Rokkones, E. / Kaern, J. / Paulsen, T. / Salvesen, H. B. / Hagen, B. / Vereide, A. B. / Fossa, S. D. et al. | 2015
- 230
-
Is the endometrial evaluation routinely required in patients with adult granulosa cell tumors of the ovary?Ottolina, J. / Ferrandina, G. / Gadducci, A. / Scollo, P. / Lorusso, D. / Giorda, G. / Breda, E. / Savarese, A. / Candiani, M. / Zullo, F. et al. | 2015
- 235
-
Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: A multi-institution studyElshaikh, M. A. / Al-Wahab, Z. / Mahdi, H. / Albuquerque, K. / Mahan, M. / Kehoe, S. M. / Ali-Fehmi, R. / Rose, P. G. / Munkarah, A. R. et al. | 2015
- 240
-
A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA)Simpkins, F. / Drake, R. / Escobar, P. F. / Nutter, B. / Rasool, N. / Rose, P. G. et al. | 2015
- 246
-
Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinomaMatulonis, U. / Vergote, I. / Backes, F. / Martin, L. P. / McMeekin, S. / Birrer, M. / Campana, F. / Xu, Y. / Egile, C. / Ghamande, S. et al. | 2015
- 254
-
Can malignant potential of endometrial polyps be determined by incorporating the endometrial intraepithelial neoplasia (EIN) classification?Naaman, Y. / Diment, J. / Perlman, S. / Oustinov, N. / Vaisbuch, E. / Ben-Arie, A. et al. | 2015
- 258
-
A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United KingdomTaylor, F. / Short, D. / Winter, M. C. / Tidy, J. / Savage, P. M. / Sarwar, N. / Hancock, B. W. / Seckl, M. J. / Coleman, R. E. et al. | 2015
- 264
-
Human placental growth hormone: A potential new biomarker in gestational trophoblastic diseaseHubener, C. / Bidlingmaier, M. / Wu, Z. / Diebold, J. / Delius, M. / Friese, K. / Strasburger, C. J. / Hasbargen, U. et al. | 2015
- 269
-
Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: Time to reconsider the FIGO staging system?Thaker, N. G. / Klopp, A. H. / Jhingran, A. / Frumovitz, M. / Iyer, R. B. / Eifel, P. J. et al. | 2015
- 274
-
Incidental power morcellation of malignancy: A retrospective cohort studyGraebe, K. / Garcia-Soto, A. / Aziz, M. / Valarezo, V. / Heller, P. B. / Tchabo, N. / Tobias, D. H. / Salamon, C. / Ramieri, J. / Dise, C. et al. | 2015
- 278
-
Surgical site infection after primary surgery for epithelial ovarian cancer: Predictors and impact on survivalTran, C. W. / McGree, M. E. / Weaver, A. L. / Martin, J. R. / Lemens, M. A. / Cliby, W. A. / Dowdy, S. C. / Bakkum-Gamez, J. N. et al. | 2015
- 285
-
Robotic transperitoneal infra-renal aortic lymphadenectomy in early-stage endometrial cancerJames, J. A. / Rakowski, J. A. / Jeppson, C. N. / Stavitzski, N. M. / Ahmad, S. / Holloway, R. W. et al. | 2015
- 293
-
A cost-utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: Incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancerCohn, D. E. / Barnett, J. C. / Wenzel, L. / Monk, B. J. / Burger, R. A. / Straughn, J. M. / Myers, E. R. / Havrilesky, L. J. et al. | 2015
- 300
-
Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysisMcCann, G. A. / Cohn, D. E. / Jewell, E. L. / Havrilesky, L. J. et al. | 2015
- 305
-
Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: Patients' and professionals' perspectivesArts-de Jong, M. / Harmsen, M. G. / Hoogerbrugge, N. / Massuger, L. F. / Hermens, R. P. / de Hullu, J. A. et al. | 2015
- 311
-
Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancerEiriksson, L. / Aronson, M. / Clarke, B. / Mojtahedi, G. / Massey, C. / Oza, A. M. / Gallinger, S. / Pollett, A. / Mackay, H. / Bernardini, M. Q. et al. | 2015
- 317
-
Content validity of the NCCN-FACT Ovarian Symptom Index-18 (NFOSI-18)Jensen, S. E. / Kaiser, K. / Lacson, L. / Schink, J. / Cella, D. et al. | 2015
- 323
-
Neurotoxicity in ovarian cancer patients on Gynecologic Oncology Group (GOG) protocol 218: Characteristics associated with toxicity and the effect of substitution with docetaxel: An NRG Oncology/Gynecologic Oncology Group studyChase, D. M. / Huang, H. / Foss, C. D. / Wenzel, L. B. / Monk, B. J. / Burger, R. A. et al. | 2015
- 328
-
Survival advantage of marriage in uterine cancer patients contrasts poor outcome for widows: A Surveillance, Epidemiology and End Results studyLowery, W. J. / Stany, M. P. / Phippen, N. T. / Bunch, K. P. / Oliver, K. E. / Tian, C. / Maxwell, G. L. / Darcy, K. M. / Hamilton, C. A. et al. | 2015
- 336
-
Distribution and case-fatality ratios by cell-type for ovarian carcinomas: A 22-year series of 562 patients with uniform current histological classificationSeidman, J. D. / Vang, R. / Ronnett, B. M. / Yemelyanova, A. / Cosin, J. A. et al. | 2015
- 341
-
Metformin and the risk of endometrial cancer: A population-based cohort studyKo, E. M. / Sturmer, T. / Hong, J. L. / Castillo, W. C. / Bae-Jump, V. / Funk, M. J. et al. | 2015
- 348
-
Three-dimensional modeling of the human fallopian tube fimbriaeEddie, S. L. / Quartuccio, S. M. / Zhu, J. / Shepherd, J. A. / Kothari, R. / Kim, J. J. / Woodruff, T. K. / Burdette, J. E. et al. | 2015
- 355
-
Brown algae phlorotannins enhance the tumoricidal effect of cisplatin and ameliorate cisplatin nephrotoxicityYang, Y. I. / Ahn, J. H. / Choi, Y. S. / Choi, J. H. et al. | 2015
- 365
-
The role of vaginal cuff brachytherapy in endometrial cancerHarkenrider, M. M. / Block, A. M. / Siddiqui, Z. A. / Small, W. et al. | 2015
- 373
-
Updates and emerging therapies for rare epithelial ovarian cancers: One size no longer fits allGroen, R. S. / Gershenson, D. M. / Fader, A. N. et al. | 2015
- 384
-
Should ovaries be removed or not in (early-stage) adenocarcinoma of the uterine cervix: A reviewOmar, T. / Marie, P. et al. | 2015
- 389
-
Mucinous metaplasia of the endometrium: Current conceptsTurashvili, G. / Childs, T. et al. | 2015
- 394
-
Advanced stage uterine adenosarcoma in a young nulligravidaCooper, K. / Everett, E. / Wong, C. et al. | 2015
- 394
-
Association of Muir-Torre Syndrome and extra-mammary Paget's: Report of the first case and discussion of the management optionsYakubova, M. / Abduilah, A. / Shariftabrizi, A. / Samuelson, R. / Shahabi, S. et al. | 2015
- 394
-
Resection of gigantic pelvic masses: Report of four cases and review of safety considerationsKakar, F. / Samuelson, R. / Shahabi, S. et al. | 2015
- 395
-
Endometrial adenocarcinoma after risk reducing bilateral salpingo-oophorectomyNaber, C. / Everett, E. / Wong, C. et al. | 2015
- 395
-
Parasitic myomas: An additional risk of uterine morcellationRauktys, A. / Kawar, N. et al. | 2015
- 395
-
Wilms Tumor 1 (WT1) as a tumor marker to detect metastatic fallopian tube cancer mimicking cervical serous carcinomaDrew, B. / Dawson, M. / Seagle, B. / Samuelson, R. / Shahabi, S. et al. | 2015
- 396
-
Preferences and expectations of OBGYN subspecialty fellowship program directors in the robotic training of incoming fellowsBregar, A. / Wohlrab, K. / Lokich, L. / Raker, C. / Clark, M. / Robison, K. et al. | 2015
- 396
-
Patient outcomes in cases of endometrial cancer and endometrial hyperplasia diagnosed following uterine morcellation at the time of hysterectomyBelniak, M. / Zhou, X. C. et al. | 2015
- 396
-
Trends in treatment of uterine serous cancer in the medicare populationAlejandro Rauh-Hain, J. / Connor, S. / Clemmer, J. / Clark, R. / Hall, T. / Growdon, W. / Goodman, A. K. / Boruta, D. / Schorge, J. / del Carmen, M. et al. | 2015
- 397
-
Cancer of the Uterus and Treatment of Incontinence (CUTI): A Pilot StudyLokich, E. / Raman, S. / Wohlrab, K. / Luis, C. / Clark, M. / Robison, K. et al. | 2015
- 397
-
Afatinib, an irreversible ErbB family blocker, demonstrates remarkable activity against HER2 amplified uterine serous endometrial cancer in vitro and in vivoSchwab, C. L. / Roque, D. M. / English, D. P. / Bellone, S. / Lopez, S. / Cocco, E. / Nicoletti, R. / Bortolomai, I. / Bonazzoli, E. / Ratner, E. et al. | 2015
- 397
-
Increased prevalence of abnormal anal cytology and high risk HPV in women with a history of lower genital tract neoplasia compared to women without a history of lower genital tract neoplasiaBregar, A. / Cronin, B. / Luis, C. / DiSilvestro, P. / Schechter, S. / Pisharodi, L. / Raker, C. / Clark, M. / Robison, K. et al. | 2015
- 398
-
Role of nuclear grade in offering adjuvant vaginal brachytherapy in stage I endometrial cancersSeagle, B. L. / Abdullah, A. / Panarelli, E. / Samuelson, R. / Rutherford, T. / Schwartz, P. / Shahabi, S. et al. | 2015
- 398
-
HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variantGrowdon, W. / Byron, V. / DiGloria, C. / Borger, D. / Foster, R. / Winslow, J. / Sperinde, J. / Rueda, B. R. et al. | 2015
- 398
-
Dual inhibition of PI3K and PARP demonstrates synergistic anti-tumor activity in endometrioid endometrial cancer patient derived xenograftsHall, T. / DiGloria, C. / Kim, M. / Zhang, L. / Foster, R. / Growdon, W. / Rueda, B. et al. | 2015
- 399
-
ROMA guided conservative management for women diagnosed with an ovarian cyst or pelvic massLokich, E. / Palisoul, M. / Romano, N. / Raker, C. / Miller, C. / Robison, K. / Stuckey, A. / McCourt, C. / DiSilvestro, P. / Mathews, C. et al. | 2015
- 399
-
Class III beta-tubulin expression in uterine cancer correlates with worse outcomesConnor, E. / Raker, C. / Lomme, M. / Dizon, D. / Grania, C. O. / Kawar, N. et al. | 2015
- 400
-
HE4-targeted antisense phosphorothioligos mitigate cisplatin resistance in epithelial ovarian cancerLokich, E. / Hill, E. K. / Han, A. / Romano, N. / Yano, N. / Kim, K. / Hovanessian, G. / Singh, R. / Moore, R. G. et al. | 2015
- 400
-
Red cell distribution width (RDW) as a novel marker for predicting recurrence of high-grade cervical dysplasia or carcinoma in active smokersDorton, B. J. / Elias, K. M. / Growdon, W. / Horowitz, N. S. et al. | 2015
- 400
-
Biological and angiogenic functions of S100A4 in ovarian cancerHan, A. / Romano, N. / Lokich, E. / Yano, N. / Kim, K. / Singh, R. / Moore, R. G. et al. | 2015
- 401
-
Solitomab, an EpCAM/CD3 bispecific antibody (BITE), is highly active against primary chemotherapy resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivoEnglish, D. P. / Bellone, S. / Schwab, C. L. / Roque, D. M. / Chatterjee, S. / Ratner, E. / Schwartz, P. E. / Rutherford, T. J. / Santin, A. D. et al. | 2015
- 401
-
Differential response to microtubule stabilizing agents of ovarian cancer cells harboring hot spot mutations of p53Salinas, A. / Hoffstetter, G. / Yang, C. P. / Shahabi, S. et al. | 2015
- 401
-
Dual targeting of EGFR desensitization with tetrathiomolybdate: Implications for cisplatin therapyKim, K. K. / Han, A. / Yano, N. / Lokich, E. / Singh, R. K. / Moore, R. G. et al. | 2015
- 402
-
The necessity of complete lymphadenectomy during surgical staging and cytoreduction of advanced ovarian cancers: A review of consecutive lymph node specimens <1cm in sizeToner, L. E. / Hatfield, B. / Seagle, B. / Sieber, S. / Samuelson, R. / Shahabi, S. et al. | 2015
- 402
-
Investigating the impact of body mass index on intraperitoneal chemotherapy outcomes in patients with advanced stage ovarian cancerDavis, M. / Rauh-Hain, A. / Worley, M. / Berkowitz, R. / Schorge, J. / Muto, M. / Growdon, W. / Horowitz, N. / Del Carmen, M. et al. | 2015
- 402
-
HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocationLokich, E. / Han, A. / Romano, N. / Yano, N. / Kim, K. / Singh, R. / Moore, R. et al. | 2015
- 403
-
Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared to fallopian tube cancerAlejandro Rauh-Hain, J. / Foley, O. W. / Winograd, D. / Andrade, C. / Clark, R. M. / Vargas, R. J. / Hinchcliff, E. M. / Esselen, K. M. / Horowitz, N. S. / del Carmen, M. G. et al. | 2015
- 403
-
Delay in chemotherapy administration adversely affects overall survival in elderly ovarian cancer patientsJoseph, N. / Clark, R. / Lee, M. / Dizon, D. S. / Growdon, W. B. et al. | 2015
- 403
-
Primary debulking surgery in advanced stage ovarian cancer is associated with improved survivalClark, R. M. / Clemmer, J. T. / Melamed, A. / Rauh-Hain, J. A. / Boruta, D. / del Carmen, M. / Goodman, A. K. / Growdon, W. B. / Hall, T. / Schorge, J. O. et al. | 2015
- 404
-
Evaluation of reliability and the predictive value of ICG directed SLN dissection in women with endometrial and cervical cancerUrh, A. / Robison, K. / Raker, C. / Steinhoff, M. / DiSilvestro, P. / McCourt, C. / Mathews, C. / Stuckey, A. / Granai, C. O. / Moore, R. G. et al. | 2015
- 404
-
Sentinel lymph node mapping predicts metastasis in endometrial cancerEmberley, E. M. / Godoy, H. / Timmins, P. F. et al. | 2015
- 404
-
Predictive factors for the presence of malignant transformation of pelvic endometriosisKadan, Y. / Fiascone, S. / McCourt, C. / Raker, C. / Granai, C. O. / Steinhoff, M. / Moore, R. G. et al. | 2015
- 405
-
Incidence and risk factors of lymphatic-related complications after robotic staging of endometrial cancerYuan, A. / Zhou, X. C. et al. | 2015
- 405
-
Safety of same day discharge in patients undergoing laparoscopic hysterectomy for endometrial intraepithelial neoplasia (EIN) and malignancyMelamed, A. / Katz, E. / Jennifer, L. / Hinchcliff, E. / Worley, M. J. / Berkowitz, R. S. / Horowitz, N. S. / Muto, M. G. / Feltmate, C. M. et al. | 2015
- 405
-
Comparison of lower extremity lymphedema incidence between two pelvic lymphadenectomy techniques in uterine cancer patients undergoing robotic-assisted staging proceduresMenderes, G. / Azodi, M. / Xu, X. / Clark, L. / Silasi, D. A. et al. | 2015
- 406
-
Next-generation sequencing demonstrates genomic signature of resistance patterns following phosphatidylinositol 3-kinase (PI3K) inhibitionRauh-Hain, A. / Kim, M. / Zhang, L. / Foster, R. / Rueda, B. / Bhasin, M. K. / Growdon, W. et al. | 2015
- 406
-
Evaluation of the 2013 NCCN guideline for reflex immunohistochemical staining in uterine cancer specimens of women aged 55 or younger to screen for Hereditary Non-polyposis Colorectal Cancer (HNPCC)Burley, H. / Jeudin, P. / Vogell, A. / Wright, V. et al. | 2015
- 407
-
Lynch syndrome screening in endometrial cancer patients with immunohistochemistry: A single center experienceVargas, R. / Rauh-Hain, J. A. / Iafrate, A. J. / Chung, D. / Ellisen, L. / Shannon, K. / Rodgers, L. / Oliva, E. / Schorge, J. et al. | 2015
- 407
-
The impact of chemotherapy on survival in uterine clear cell carcinoma patientsRauh-Hain, J. A. / Gockley, A. / Clemmer, J. / Clark, R. M. / Hall, T. / Growdon, W. / Goodman, A. K. / Boruta, D. / Schorge, J. / del Carman, M. et al. | 2015
- 407
-
The endoglin-BMP9 axis as a predictor of methotrexate resistance in low-risk gestational trophoblastic neoplasiaElias, K. M. / Hasselblatt, K. T. / Harvey, R. A. / Berkowitz, R. S. / Seckl, M. J. / Horowitz, N. S. et al. | 2015
- 408
-
Comparison of surgical outcome and survival for obese women with endometrial cancer following three surgical approaches: Conventional laparoscopy, robotic laparoscopy and laparotomyEltabbakh, G. H. / Donovan, E. M. / Eltabbakh, G. D. et al. | 2015
- 408
-
Gemcitabine and docetaxel compared to alternative chemotherapy regimens as adjuvant treatment for uterine leiomyosarcomaTaylor, K. / Palisoul, M. / Roque, D. R. / Kim, H. / Wysham, W. / Gehrig, P. A. / Raker, C. / Robison, K. et al. | 2015
- 408
-
Trends in utilization and outcomes with plastic surgery for vulvar closure following vulvectomy for invasive squamous cell cancerAviki, E. M. / Esselen, K. M. / Barcia, S. M. / Horowitz, N. S. / Feltmate, C. M. / Berkowitz, R. S. / Nucci, M. R. / Muto, M. G. et al. | 2015
- 409
-
The natural history and outcomes of vaginal sarcoma - A Surveillance, Epidemiology, and End Results database analysisGhezelayagh, T. / Growdon, W. B. et al. | 2015
- 409
-
Racial disparities and trends in treatment of high-grade endometrial cancer in the medicare populationBuskwofie, A. / Rauh-Hain, J. A. / Clemmer, J. / Clark, R. M. / Hall, T. / Growdon, W. B. / Goodman, A. K. / Boruta, D. M. / Schorge, J. O. / Del Carmen, M. G. et al. | 2015
- 409
-
Teaching by teleconference: The Massachusetts General Hospital - Ugandan experienceNgonzi, J. / Boatin, A. / Mugyenyi, G. / Bradford, L. / Clark, R. / Wylie, B. / Goodman, A. et al. | 2015
- 410
-
Preoperative genetic testing affects surgical decision making in breast cancer patientsLokich, E. / Stuckey, A. / Raker, C. / Wilber, J. S. / Laprise, J. / Gass, J. et al. | 2015
- 410
-
Surgical management of breast cancer and impact on sexual functionFogarty, S. / Onstad, M. / Stuckey, A. / Kunkel, E. / Clark, M. / Lopes, V. / Raker, C. / Robison, K. / Flores, L. / Boggis, J. et al. | 2015
- 410
-
Anchoring bias in gynecologic oncologyShalowitz, D. I. / Schorge, J. O. et al. | 2015
- 411
-
Readability of online patient resources in gynecologic oncology: Too difficult for our patients to read?Vargas, R. / Esselen, K. / Muto, M. et al. | 2015
-
Editorial Board| 2015